Methotrexate in the treatment of penile carcinoma
- 14 January 1980
- Vol. 45 (2) , 214-216
- https://doi.org/10.1002/1097-0142(19800115)45:2<214::aid-cncr2820450203>3.0.co;2-k
Abstract
Eight patients with epidermoid carcinoma of the penis received methotrexate, five with high-dose methotrexate, 250–1500 mg/m2 with citrovorum rescue Q 2–4 weeks, and three with low-dose methotrexate, 0.5–3.0 mg/kg weekly. Three (38%) patients achieved a complete or partial remission which persisted for 11, 3 and 2 months, respectively. Methotrexate appears to be an active agent in the treatment of advanced penile cancer.This publication has 5 references indexed in Scilit:
- Cis-diamminedichloride platinum II (DDP) in the treatment of penile carcinomaCancer, 1979
- Bleomycin, an Antitumor AntibioticAnnals of Internal Medicine, 1972
- Carcinoma of the penis in uganda and kenya africansCancer, 1963
- Clinical evaluation of cancer chemotherapy with 5-fluorouracilCancer, 1961